Rapamycin and chronic kidney disease: beyond the inhibition of inflammation
- PMID: 16724087
- DOI: 10.1038/sj.ki.5001543
Rapamycin and chronic kidney disease: beyond the inhibition of inflammation
Abstract
Rapamycin, a potent inhibitor of the mammalian target of rapamycin (mTOR) protein kinase, is a well-known immunosuppressive agent. In this issue, Wu and colleagues report that rapamycin significantly attenuates renal interstitial fibrosis in obstructive nephropathy. Besides its inhibition of renal inflammation, rapamycin is able to block tubular epithelial-mesenchymal transition, thereby shedding new light on the mechanism of its antifibrotic actions.
Comment on
-
Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis.Kidney Int. 2006 Jun;69(11):2029-36. doi: 10.1038/sj.ki.5000161. Kidney Int. 2006. PMID: 16732193
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
